Dale Lee1, James D Lewis2,3, Justine Shults3, Robert N Baldassano4, Jin Long5, Rita Herskovitz4, Babette Zemel4, Mary B Leonard5,6. 1. Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington. 2. Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 3. Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania. 4. Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 5. Department of Medicine, Stanford University, Stanford, California. 6. Department of Pediatrics, Stanford University, Stanford, California.
Abstract
Background: In pediatric Crohn's disease, fat mass improves over time with treatment, but lean mass deficits persist. This observational study of the associations of physical activity and dietary intake with lean mass and muscle strength in children with Crohn's disease was ancillary to a previously reported randomized clinical trial of an intervention to improve bone health. Methods: In this study, 138 participants were followed at baseline and at 6, 12, and 24 months with evaluation of lean and fat mass using DXA, muscle strength (peak torque), Crohn's characteristics, dietary intake, time in moderate to vigorous physical activity (MVPA), and serum insulin-like growth factor-1 (IGF-1) and tumor necrosis factor-alpha (TNF-α). Race- and sex-specific Z-scores for leg lean mass and whole body fat mass were generated. Quasi least square regression evaluated determinants of changes in body composition and muscle strength. Results: Leg lean mass and muscle strength were positively associated with time in MVPA (P < 0.05) and negatively associated with increasing clinical disease activity (P < 0.05). Both leg lean mass and strength were positively associated with IGF-1 Z-score (P ≤ 0.03) but negatively associated with serum TNF-α (P ≤ 0.04). Neither lean mass nor muscle strength was associated with caloric or protein intake. Conclusions: Persistence of lean mass deficits was related to ongoing Crohn's disease activity but improved with greater time spent in moderate to vigorous physical activity. Future trials are needed to evaluate the efficacy of physical activity in improving lean mass in pediatric Crohn's disease.
Background: In pediatric Crohn's disease, fat mass improves over time with treatment, but lean mass deficits persist. This observational study of the associations of physical activity and dietary intake with lean mass and muscle strength in children with Crohn's disease was ancillary to a previously reported randomized clinical trial of an intervention to improve bone health. Methods: In this study, 138 participants were followed at baseline and at 6, 12, and 24 months with evaluation of lean and fat mass using DXA, muscle strength (peak torque), Crohn's characteristics, dietary intake, time in moderate to vigorous physical activity (MVPA), and serum insulin-like growth factor-1 (IGF-1) and tumor necrosis factor-alpha (TNF-α). Race- and sex-specific Z-scores for leg lean mass and whole body fat mass were generated. Quasi least square regression evaluated determinants of changes in body composition and muscle strength. Results:Leg lean mass and muscle strength were positively associated with time in MVPA (P < 0.05) and negatively associated with increasing clinical disease activity (P < 0.05). Both leg lean mass and strength were positively associated with IGF-1 Z-score (P ≤ 0.03) but negatively associated with serum TNF-α (P ≤ 0.04). Neither lean mass nor muscle strength was associated with caloric or protein intake. Conclusions: Persistence of lean mass deficits was related to ongoing Crohn's disease activity but improved with greater time spent in moderate to vigorous physical activity. Future trials are needed to evaluate the efficacy of physical activity in improving lean mass in pediatric Crohn's disease.
Authors: Sogol Mostoufi-Moab; Jeremy Magland; Elizabeth J Isaacoff; Wenli Sun; Chamith S Rajapakse; Babette Zemel; Felix Wehrli; Karuna Shekdar; Joshua Baker; Jin Long; Mary B Leonard Journal: J Bone Miner Res Date: 2015-05-10 Impact factor: 6.741
Authors: Lindsay M Griffin; Heidi J Kalkwarf; Babette S Zemel; Justine Shults; Rachel J Wetzsteon; C Frederic Strife; Mary B Leonard Journal: Pediatr Nephrol Date: 2012-02-16 Impact factor: 3.714
Authors: Babette S Zemel; Mary B Leonard; Andrea Kelly; Joan M Lappe; Vicente Gilsanz; Sharon Oberfield; Soroosh Mahboubi; John A Shepherd; Thomas N Hangartner; Margaret M Frederick; Karen K Winer; Heidi J Kalkwarf Journal: J Clin Endocrinol Metab Date: 2010-01-26 Impact factor: 5.958
Authors: Arie Levine; Anne Griffiths; James Markowitz; David C Wilson; Dan Turner; Richard K Russell; John Fell; Frank M Ruemmele; Thomas Walters; Mary Sherlock; Marla Dubinsky; Jeffrey S Hyams Journal: Inflamm Bowel Dis Date: 2010-11-08 Impact factor: 5.325
Authors: Lisa Dowling; Philip Jakeman; Catherine Norton; Maeve M Skelly; Hamid Yousuf; Miranda G Kiernan; Margaret Toomey; Sheila Bowers; Suzanne S Dunne; J Calvin Coffey; Colum P Dunne Journal: Sci Rep Date: 2021-09-28 Impact factor: 4.379